Strahlentherapie des Mediastinalen Hodgkin-Lymphoms

Literaturverzeichnis
Engert, A., and Klimm, B. (2009). Hodgkin-Lymphome. In Innere Medizin, M. Böhm, M. Hallek, and W.
Schmiegel, eds. (München: Urban & Fischer), pp. 524-527.
Engert, A., Schiller, P., Josting, A., Herrmann, R., Koch, P., Sieber, M., Boissevain, F., De Wit, M., Mezger, J.,
Duhmke, E., Willich, N., Muller, R.P., Schmidt, B.F., Renner, H., Muller-Hermelink, H.K., Pfistner, B., Wolf,
J., Hasenclever, D., Loffler, M., and Diehl, V. (2003). Involved-field radiotherapy is equally effective and less
toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage
unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group. J
Clin Oncol 21, 3601-3608.
Evens, A.M., Sweetenham, J.W., and Horning, S.J. (2008). Hodgkin lymphoma in older patients: an uncommon
disease in need of study. Oncology (Williston Park) 22, 1369-1379.
Fan, Z.M.D., Natkunam, Y.M.D.P., Bair, E.B.S.M.S., Tibshirani, R.P., and Warnke, R.A.M.D. (2003).
Characterization of Variant Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma with
Immunohistologic and Clinical Correlation. American Journal of Surgical Pathology 27, 1346-1356.
Favier, O., Heutte, N., Stamatoullas-Bastard, A., Carde, P., Van't Veer, M.B., Aleman, B.M., Noordijk, E.M.,
Thomas, J., Ferme, C., and Henry-Amar, M. (2009). Survival after Hodgkin lymphoma: causes of death and
excess mortality in patients treated in 8 consecutive trials. Cancer 115, 1680-1691.
Ferme, C., Divine, M., Vranovsky, A., Morschhauser, F., Bouabdallah, R., Gabarre, J., Bastard-Stamatoullas, A.,
Delarue, R., Zagonel, V., Jaubert, J., Hagenbeek, A., Kramer, M.H.H., Rieux, C., Thomas, J., and Henry-Amar,
M. (2005). Four ABVD and Involved-Field Radiotherapy in Unfavorable Supradiaphragmatic Clinical Stages
(CS) I-II Hodgkin's Lymphoma (HL): Preliminary Results of the EORTC-GELA H9-U Trial. ASH Annual
Meeting Abstracts 106, 813.
Ferme, C., Eghbali, H., Meerwaldt, J.H., Rieux, C., Bosq, J., Berger, F., Girinsky, T., Brice, P., van't Veer, M.B.,
Walewski, J.A., Lederlin, P., Tirelli, U., Carde, P., Van den Neste, E., Gyan, E., Monconduit, M., Divine, M.,
Raemaekers, J.M., Salles, G., Noordijk, E.M., Creemers, G.J., Gabarre, J., Hagenbeek, A., Reman, O., Blanc,
M., Thomas, J., Vie, B., Kluin-Nelemans, J.C., Viseu, F., Baars, J.W., Poortmans, P., Lugtenburg, P.J., Carrie,
C., Jaubert, J., and Henry-Amar, M. (2007). Chemotherapy plus involved-field radiation in early-stage Hodgkin's
disease. N Engl J Med 357, 1916-1927.
Feuvret, L., Noel, G., Mazeron, J.J., and Bey, P. (2006). Conformity index: a review. Int J Radiat Oncol Biol
Phys 64, 333-342.
Fippel, M. (1999). Fast Monte Carlo dose calculation for photon beams based on the VMC electron algorithm.
Med Phys 26, 1466-1475.
Fippel, M., Haryanto, F., Dohm, O., Nüsslin, F., and Kriesen, S. (2003). A virtual photon energy fluence model
for Monte Carlo dose calculation. Med Phys 30, 301-311.
Fippel, M., Laub, W., Huber, B., and Nüsslin, F. (1999). Experimental investigation of a fast Monte Carlo
photon beam dose calculation algorithm. Phys Med Biol 44, 3039-3054.
Fotina, I., Kragl, G., Kroupa, B., Trausmuth, R., and Georg, D. (2011). Clinical comparison of dose calculation
using the enhanced collapsed cone algorithm vs. a new Monte Carlo algorithm. Strahlenther Onkol 187, 433-
441.
Franklin, J., Pluetschow, A., Paus, M., Specht, L., Anselmo, A.P., Aviles, A., Biti, G., Bogatyreva, T.,
Bonadonna, G., Brillant, C., Cavalieri, E., Diehl, V., Eghbali, H., Ferme, C., Henry-Amar, M., Hoppe, R.,
Howard, S., Meyer, R., Niedzwiecki, D., Pavlovsky, S., Radford, J., Raemaekers, J., Ryder, D., Schiller, P.,
Shakhtarina, S., Valagussa, P., Wilimas, J., and Yahalom, J. (2006). Second malignancy risk associated with
treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials. Ann Oncol 17, 1749-1760.
Gagliardi, G., Constine, L.S., Moiseenko, V., Correa, C., Pierce, L.J., Allen, A.M., and Marks, L.B. (2010).
Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys 76, 77-85.
Ganz, P.A., and Bower, J.E. (2007). Cancer related fatigue: a focus on breast cancer and Hodgkin's disease
survivors. Acta Oncol 46, 474-479.
Gaya, A.M., and Ashford, R.F. (2005). Cardiac complications of radiation therapy. Clin Oncol (R Coll Radiol)
17, 153-159.
Gilbert, E.S., Stovall, M., Gospodarowicz, M., Van Leeuwen, F.E., Andersson, M., Glimelius, B., Joensuu, T.,
Lynch, C.F., Curtis, R.E., Holowaty, E., Storm, H., Pukkala, E., van't Veer, M.B., Fraumeni, J.F., Boice, J.D.,
Jr., Clarke, E.A., and Travis, L.B. (2003). Lung cancer after treatment for Hodgkin's disease: focus on radiation
effects. Radiat Res 159, 161-173.
126